rs112445441
A SNP in the KRAS gene on chromosome 12. Its most notable genotype is A;C: Drug response to cetuximab and panitumumab
- Gene
- KRAS
- Location
- Chr 1225,245,347 (GRCh38)
- Highest magnitude
- 3.0Important
- Tested on
- AncestryDNA
Genotypes
As shown in 23andMe and AncestryDNA files.
- A;CMost notableBadDrug response to cetuximab and panitumumab
- C;CGoodcommon in clinvar
- G;GGoodcommon in complete genomics
On SNPedia: (A;C), (C;C), (G;G). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Related
Conditions, medicines and genes
Other KRAS SNPs
- rs104894359C;GNoonan syndromeVery important
- rs104894360A;TNoonan syndromeVery important
- rs104894361A;TNoonan syndromeVery important
- rs104894364A;GNoonan syndromeVery important
- rs104894365C;TNoonan syndromeVery important
- rs104894366C;GNoonan syndromeVery important
- rs727503110C;TNoonan syndromeVery important
- rs712A;Acommon in clinvarTypical
Notes
From SNPedia
Notes
aka c.38G>T (p.Gly13Val) annotated in ClinVar as a somatic mutation, and also for its PGx association (drug response to cetuximab and panitumumab) 23andMe name for the c.38G>A variant: i5002724
A;C
see links on main rs-page, especially to PharmGKB via ClinVar
Source and license
Adapted from rs112445441 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.